Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.43 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13005524 | 1.00 | MME (0.43) | MMEMMEL1ROCK2ROCK1HDAC4 | |
| SCHEMBL13005652 | 0.93 | TAS1R3 (0.43) | MMEMMEL1ALDH1A1GPR139CTRB1 | |
| SCHEMBL13005647 | 0.93 | TAS1R3 (0.43) | MMEMMEL1ALDH1A1GPR139CTRB1 | |
| SCHEMBL13061226 | 0.93 | ROCK2 (0.44) | MMEMMEL1ROCK2ROCK1HDAC4 | |
| SCHEMBL13060643 | 0.93 | ROCK2 (0.44) | MMEMMEL1ROCK2ROCK1HDAC4 | |
| SCHEMBL13005472 | 0.90 | CTSL (0.41) | ROCK2ROCK1HDAC4CTSL | |
| SCHEMBL13005481 | 0.90 | CTSL (0.41) | ROCK2ROCK1HDAC4CTSL | |
| SCHEMBL13005639 | 0.87 | ROCK2 (0.38) | ROCK2ROCK1CTSL | |
| SCHEMBL13005620 | 0.87 | ROCK2 (0.38) | ROCK2ROCK1CTSL | |
| SCHEMBL13005693 | 0.86 | ROCK2 (0.50) | ROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851637-B2 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | INFINITY PHARMACEUTICALS, INC. (US) | 2010-12-14 | — | — | US | disclosed |
| US-7851637-B2 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | INFINITY PHARMACEUTICALS, INC. (US) | 2010-12-14 | — | — | US | disclosed |